Positron emission tomography (PET) remains a cornerstone of biomedical imaging, offering a non‐invasive technique to visualise metabolic processes and molecular pathways in vivo. Central to the ...

Positron Emission Tomography (PET) has long served as a critical medical imaging modality, enabling the visualisation of biochemical processes in vivo using positron-emitting radiotracers. Recent ...

We identified patients from four institutions who underwent PSMA PET/CT scans pretreatment for primary staging or postradical prostatectomy (RP) for suspected recurrence and had Decipher ...

A research group at Uppsala University has demonstrated that a new method for PET imaging of Alzheimer's disease is effective ...

Positron emission tomography (PET) is a type of imaging scan that doctors might use when diagnosing and treating non-Hodgkin’s lymphoma (NHL). It can be useful for identifying and staging the cancer.

SAN DIEGO--(BUSINESS WIRE)-- Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of ...

- PIPE-791 achieved high LPA1 brain receptor occupancy (RO) in healthy volunteers and progressive multiple sclerosis (PrMS) patients - PIPE-791 showed a safety and tolerability profile consistent with ...

Niagara Falls, NY, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (POSC), a leading molecular imaging medical device company specializing in PET and PET-CT (Positron Emission ...

Risk of Further Progression or Death Among Durable Progression-Free Survivors With Melanoma or Non–Small-Cell Lung Cancer in PD-1 Blockade Trials: Implications for Imaging Surveillance This ...

YARDLEY, Pa.--(BUSINESS WIRE)--Jubilant Radiopharma’s Radiopharmacies division is excited to announce an investment of $50 million (USD) to expand its PET radiopharmaceutical manufacturing facilities ...